Evidence map›Paper›PMID 36714175›Full record

ArticleBlood cell therapy2020

Evolution of Hematopoietic Stem Cell Transplant Programs in Malaysia.

Norashikin Saidon, Nur Adila Anuar, Chang Kian Meng, Ong Tee Chuan, Tan Sen Mui, Gan Gin Gin, Fadilah Saw, Hany Ariffin, Lin Hai Peng, Chan Lee Lee and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cell therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Norashikin SaidonFaculty of Medicine, Sungai Buloh, Universiti Teknologi MARA, Malaysia.
Nur Adila AnuarHematology Unit, University of Malaya Medical Center, Malaysia.
Chang Kian MengSunway Medical Center, Malaysia.
Ong Tee ChuanHematology Department, Hospital Ampang, Malaysia.
Tan Sen MuiHematology Department, Hospital Ampang, Malaysia.
Gan Gin GinHematology Unit, University of Malaya Medical Center, Malaysia.
Fadilah SawDepartment of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Malaysia.
Hany AriffinDepartment of Pediatrics, University of Malaya Medical Center, Malaysia.
Lin Hai PengSubang Jaya Medical Center, Malaysia.
Chan Lee LeeSubang Jaya Medical Center, Malaysia.
Alan TehSubang Jaya Medical Center, Malaysia.
Bee Ping ChongHematology Unit, University of Malaya Medical Center, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematopoietic stem cell transplantation (HSCT) is now widely practiced worldwide. It has the potential to cure many hematological diseases, such as acute leukemia and thalassemia. As an emerging country, Malaysia has made advancements despite many challenges. HSCT has evolved rapidly since the first pediatric allogeneic HSCT case in 1987. The first adult HSCT was performed 5 years later in 1993. Currently, a total of 13 hospitals offer HSCT services throughout Malaysia. These include private healthcare services, substantially funded government hospitals governed by the Ministry of Health, and partially funded teaching hospitals governed by the Ministry of Education. Until 2015, 1,987 allogeneic and 1,648 autologous HSCT procedures were performed. This article narrates the history and development of HSCT in Malaysia and briefly discusses the challenging issues in this area.

Indexed as

allogeneicautologoushaploidenticalhematopoietic stem cell transplantMalaysia

Identifiers

PMID36714175
PMCPMC9847264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.